Dog Allergy Shots Side Effects: What to Expect Before You Start

The most common side effects of dog allergy shots are local injection-site reactions: redness, swelling, and pruritus at the injection arm, occurring in 26-86% of SCIT patients across published cohorts. These are expected, self-limiting, and do not require dose adjustment for a single occurrence per the AAAAI/ACAAI Practice Parameter (Cox et al., JACI 2011). A small wheal at the injection site that resolves within hours is the typical experience. Some patients develop late-phase swelling 6-12 hours after the injection that peaks at 24-48 hours and resolves over several days. Fatigue after injections — particularly during the escalating doses of build-up — is reported by patients and thought to reflect cytokine-mediated immune activation. Systemic reactions affecting the whole body occur in approximately 0.1-0.2% of injection visits and require the standard epinephrine-ready clinical supervision.

Local injection-site reactions from dog allergy shots typically resolve within hours for a simple wheal. Late-phase swelling can emerge 6-12 hours after the injection, peak at 24-48 hours, and fully resolve over 2-5 days for larger reactions. These are expected as part of the immune response during build-up. Systemic reactions — if they occur — require evaluation and dose adjustment before the next injection. Post-injection fatigue, when experienced, typically lasts hours to approximately 24 hours and tends to occur more often during build-up when doses are rapidly increasing. The overall burden of side effects typically decreases as treatment progresses from build-up to maintenance: once the maintenance dose stabilizes, local reactions often diminish in size and intensity as the injection site becomes acclimatized to the allergen.

Living with a dog during allergy shot treatment does not worsen the injection-related side effects directly, but it does affect the overall symptom burden during the build-up phase. Ongoing high-level natural allergen exposure from your dog at home means your immune system is continuously stimulated by dog allergens — while simultaneously receiving escalating doses through injections. During early build-up, this overlap can produce more prominent respiratory symptoms (nasal congestion, eye irritation, asthma flares) than would occur in a patient who removed the dog from the environment. These home-exposure symptoms can be difficult to distinguish from injection reactions without careful symptom tracking. Concurrent environmental controls — HEPA air purifiers, bedroom dog exclusion, regular dog bathing, hand washing after contact — are standard recommendations to reduce the natural exposure component during treatment.

Most patients receiving dog allergy shots notice meaningful symptom improvement at 6-12 months of consistent treatment (Cox et al., JACI 2011). This timeline reflects the biological reality of immune desensitization: it takes sustained allergen exposure through the build-up phase to shift the immune response from IgE-dominated allergy toward IgG4 blocking-antibody-dominated tolerance. Full benefit typically reaches its maximum at 2-3 years of treatment, with the 3-5 year course recommended to establish durable, post-treatment tolerance. It is worth noting that improvement timelines for dog SCIT may be less predictable than for standardized allergens like cat or grass, partly due to extract non-standardization — if the prescribed extract underrepresents your specific dog allergen sensitization (particularly Can f 5 if you are sensitized to it), the clinical response may be incomplete even with adequate time on treatment.

If dog allergy shots are not producing meaningful symptom improvement after 12-18 months of consistent maintenance-phase treatment, several possibilities should be investigated with your allergist. First, assess whether your extract adequately covers your sensitization profile — Can f 5 (a major dog allergen absent from many commercial extracts) affects approximately 70% of dog-allergic patients, and if you are sensitized to it but your extract lacks it, treatment may be targeting the wrong allergens. Second, review whether the dose being delivered is at or near the recommended therapeutic maintenance dose — inadequate dosing due to extract potency variability is a known limitation of non-standardized dog extract. Third, consider whether other allergens are contributing significantly to your symptoms — most dog-allergic patients are also sensitized to cat, dust mite, pollen, or other environmental triggers that may require concurrent treatment. Switching to a different manufacturer's extract or exploring SLIT drops as an alternative delivery route are options to discuss with your allergist if SCIT is not succeeding.

Evidence suggests that SCIT for aeroallergen allergy, including dog allergy, can reduce asthma symptoms triggered by the treated allergen. The PAT Study (Jacobsen 2007, Allergy) demonstrated that allergen immunotherapy in children with rhinitis reduced the development of asthma at 10-year follow-up. For dog-specifically-triggered asthma, the evidence base is less robust — there are no large RCTs specifically evaluating dog SCIT for asthma outcomes comparable to the grass or dust mite SCIT asthma literature. Asthma management during SCIT is critical from a safety standpoint: uncontrolled asthma (FEV1 below 70% predicted) is a contraindication to receiving injections because impaired respiratory reserve dramatically increases the risk of severe anaphylaxis. Your allergist should confirm asthma control with spirometry before initiating dog SCIT, and pre-injection asthma screening is recommended before each visit.